ArticleFrontiers in pharmacology2022

A Randomized Controlled Dose-Escalation Study of LY06006, a Recombinant Humanized Monoclonal Antibody to RANKL, in Chinese Healthy Adults.

Suping Niu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.